| All Releases
|
|---|
 |
Cytori to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
May 12, 2008
|
7.1 KB
|
| |
SAN DIEGO, May 12, 2008 (BUSINESS WIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will present and provide an audio webcast of its corporate presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo, Monaco on May 19, 2008 at 3:40 A.M. Eastern Daylight Time.
The audio webcast may be accessed under "Events & W...
|
|
|
Cytori Reports First Celution(R) System Revenues During the First Quarter; Provides Update on Celution(R) System Commercialization
May 9, 2008
|
16.1 KB
|
| |
SAN DIEGO, May 09, 2008 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) achieves first Celution(R) System revenues in the quarter ended March 31, 2008.
"Demand for the Celution 800 System has been very encouraging within the European and Asian reconstructive surgery market," said Christopher J. Calhoun, chief executive officer of Cytori. "...
|
|
|
Cytori Begins Breast Reconstruction Study in Europe
May 1, 2008
|
9.3 KB
|
| |
SAN DIEGO, May 01, 2008 (BUSINESS WIRE) -- Cytori (NASDAQ:CYTX) received approval to begin its European stem and regenerative cell-enhanced breast reconstruction study in breast cancer patients who have undergone partial mastectomy. This is a post-market study designated as RESTORE II. Currently, there is no generally accepted reconstructive techni...
|
|
|
Cytori Closes 2nd Half of $12 Million Equity Agreement with Green Hospital Supply
Apr 30, 2008
|
6.8 KB
|
| |
SAN DIEGO, Apr 30, 2008 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) received the second $6.0 million payment from Green Hospital Supply, Inc. (TOKYO:3360) in exchange for 1 million shares of Cytori common stock. This was the final installment of a $12 million equity agreement entered into on February 8, 2008 for the sale of 2.0 million sha...
|
|
|
Cytori Therapeutics to Webcast 1st Quarter Results on May 9, 2008
Apr 23, 2008
|
6.5 KB
|
| |
SAN DIEGO, Apr 23, 2008 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) to report financial results for the quarter ended March 31, 2008, on Friday, May 9, at approximately 8 a.m. Eastern Daylight Time (EDT). The company will host a conference call at 10:00 a.m. (EDT).
The audio webcast of the conference call may be accessed under "Events ...
|
|
|
Nagasaki University Awarded Clinical Research Grant to Study Cell-Enhanced Reconstruction in HIV Therapy-Induced Facial Atrophy Using Celution® 800 System
Apr 9, 2008
|
7.4 KB
|
| |
SAN DIEGO & NAGASAKI, Japan, Apr 09, 2008 (BUSINESS WIRE) -- Nagasaki University will sponsor and perform a clinical study on the use of cell-enhanced reconstruction in HIV therapy-induced facial atrophy, a condition where adipose (fat) tissue becomes unevenly lost, leaving patients with a gaunt appearance. The study will be funded through a three ...
|
|
|
Enrollment Completed for Investigator-Initiated Stem & Regenerative Cell Breast Augmentation Study in Japan
Apr 3, 2008
|
7.8 KB
|
| |
TOKYO, Apr 03, 2008 (BUSINESS WIRE) -- Enrollment was completed in a 20 patient investigator-initiated study in Japan using adipose-derived stem and regenerative cells in breast augmentation procedures. The study, which began November 2007, is evaluating a procedure whereby a woman's fat tissue is enriched with her own adipose derived stem and rege...
|
|
|
Cytori Reports 4th Quarter and Year End Results; Provides Update on Commercialization Progress
Mar 12, 2008
|
15.0 KB
|
| |
SAN DIEGO, Mar 12, 2008 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) reports financial results for the year and quarter ended December 31, 2007, reviews 2007 highlights, and provides update on Celution(TM) System commercialization progress.
"In 2007, we established the foundation for the commercial introduction of the Celution(TM) Syste...
|
|
|
Cytori Closes First Half of $12 Million Equity Agreement with Green Hospital Supply
Feb 29, 2008
|
6.9 KB
|
| |
SAN DIEGO, Feb 29, 2008 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ: CYTX) closed the first half of its $12 million equity agreement with Green Hospital Supply, Inc. (TOKYO: 3360), which the companies entered into on February 8, 2008. Under this agreement, Green Hospital Supply committed to purchase 2.0 million shares of unregistered common stoc...
|
|
|
Cytori Recognized by Frost & Sullivan for Medical Device and Regenerative Medicine Innovation
Feb 27, 2008
|
8.9 KB
|
| |
SAN DIEGO, Feb 27, 2008 (BUSINESS WIRE) -- Frost & Sullivan awarded Cytori Therapeutics, Inc. (NASDAQ:CYTX) the 2008 North American Regenerative Medicine Technology Innovation of the Year Award and the 2008 United States Medical Device Industry Innovation & Advancement of the Year Award. The two distinct awards recognize Cytori's development and co...
|
|
|
Cell-Enhanced Breast Reconstruction Study Shows Sustained Improvement at 12-Months
Feb 22, 2008
|
8.0 KB
|
| |
SAN DIEGO, Feb 22, 2008 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) was informed that positive longer-term follow-up data were presented today from an independent, investigator-sponsored breast reconstruction study in Japan. As part of the study, adipose tissue-derived stem and regenerative cells, processed with Cytori's Celution
|
|
|
Cytori Therapeutics to Webcast 4th Quarter and Year End Results on March 12, 2008
Feb 19, 2008
|
6.5 KB
|
| |
SAN DIEGO, Feb 19, 2008 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) reports financial results for the year and quarter ended December 31, 2007 and provides update on Celution(TM) System commercialization progress.
The audio webcast of the conference call may be accessed under "Events & Webcasts" in the Investor Relations section of the...
|
|
|
Cytori Receives First Celution™ 800 System Orders in Europe and Asia;
Begins Commercialization into the Reconstructive Surgery Market
Feb 13, 2008
|
6.8 KB
|
| |
February 13, 2008, San Diego, Calif. – Cytori Therapeutics (NASDAQ: CYTX) received its first orders from Europe and Asia for Celution™ 800 Systems. The devices are now being sold into the growing international reconstructive surgery market. Eleven Celution™ 800 Systems and related CT-805 single-use consumables were ordered by Cytori'...
|
|
|
Cytori to Raise $12 Million in Strategic Equity Agreement with Green Hospital Supply
Feb 8, 2008
|
7.1 KB
|
| |
February 8, 2008, San Diego, Calif., – Cytori Therapeutics, Inc. (NASDAQ: CYTX) entered into a strategic equity agreement with Green Hospital Supply, Inc. (Tokyo: 3360). Green Hospital Supply, Cytori's StemSource™ commercialization partner for Japan, will purchase 2.0 million shares of unregistered Cytori common stock at $6.00 per share...
|
|
|
First Patients Treated in Cytori's Stem & Regenerative Cell Heart Attack Study
Jan 29, 2008
|
8.7 KB
|
| |
January 30, San Diego, Calif -- Cytori Therapeutics (NASDAQ: CYTX) enrolled the first two patients in a clinical trial using adipose-derived stem and regenerative cells in the treatment of heart attack. In this trial, patients' cells are made available using Cytori's Celution™ System, a real-time cell processing device. One...
|
|
|
Cytori to Present at the 2008 Wachovia Healthcare Conference on January 31
Jan 22, 2008
|
6.6 KB
|
| |
January 22, 2008, San Diego, Calif., - Cytori Therapeutics, Inc., (NASDAQ: CYTX) will present and provide an audio webcast of its corporate presentation at the 2008 Wachovia Healthcare Conference in Boston on January 31, 2008 at 8:30 a.m. Eastern Standard Time.
The audio webcast may be accessed under "Events & Webcasts" in th...
|
|
|
Cytori to Present at the Stanford Group Company 13th Annual Healthcare Conference January 17
Jan 7, 2008
|
5.9 KB
|
| |
January 7, 2008, San Diego, Calif., - Cytori Therapeutics, Inc., (NASDAQ: CYTX) will present and provide an audio webcast of its corporate presentation at the Stanford Group Company 13th Annual Healthcare Conference on January 17, 2008 at 1:15 p.m. Eastern Standard Time.
The audio webcast may be accessed under "Even...
|
|
|
Cytori Appoints Richard J Hawkins, Senior Life Science Executive, to Board of Directors
Dec 20, 2007
|
7.2 KB
|
| |
San Diego, CA, December 20, 2007 -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) announces appointment of Richard J. Hawkins, Chairman and CEO of LabNow Inc., to serve as an independent member on Cytori's Board of Directors. Mr. Hawkins brings over 30 years experience as a founder, Chief Executive Officer, and strategic advisor in the drug develop...
|
|
|
Adipose-Derived Stem Cells Show Promise in Breast Reconstruction
Dec 15, 2007
|
9.6 KB
|
| |
December 15, 2007, San Diego, CA - Cytori Therapeutics (NASDAQ: CYTX) received results from an independent, investigator-sponsored study in Japan in which adipose tissue-derived stem and regenerative cells were used for breast reconstruction following partial mastectomy. The study data were presented today at the 30th San Antonio Breast C...
|
|
|
Adipose-Derived Stem & Regenerative Cells Improve Fat Graft Retention in Preclinical Study
Dec 15, 2007
|
7.7 KB
|
| |
December 15, 2007, San Antonio, Texas -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported positive preclinical results demonstrating adipose-derived stem and regenerative cells improved the quality and long-term retention of a fat graft, representing a potential new approach in reconstructive surgery. The benefit of adipose-derived stem and reg...
|
|
|
